MedPath

The comparative study of the change of blood sugar consentration with feeding by "Inslow(Meiji Co., Ltd.)" or contral formula after surgery for gastric cancer who are Diabetes Mellitus or glucose intolerance.

Not Applicable
Conditions
The patients who are planed the surgery to gastric cancer with diabetes mellitus or glucose intolerance as 5.9 and over 7.5 and less in HbA1c.
Registration Number
JPRN-UMIN000005807
Lead Sponsor
Toho University Medical Center Omori Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

a

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1,5-AG
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath